$CBNT
C-Bond Systems, Inc Stock $cbnt

$cbnt Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000121390024042971 Filed on May 14, 2024

Income Statement

Concept	2024 Q2	2024 Q1	2023 Q1
Revenue	$863.5K	$936.8K	$515.2K
YoY Change	108.56%	81.83%	0.88%
Cost Of Revenue	$425.0K	$461.9K	$245.4K
YoY Change	103.26%	88.27%	-1.71%
Gross Profit	$438.6K	$474.9K	$269.9K
YoY Change	113.96%	75.97%	3.36%
Gross Profit Margin	50.79%	50.69%	52.38%
Selling, General & Admin	$619.1K	$1.105M	$785.2K
YoY Change	-19.49%	40.66%	-59.2%
% of Gross Profit	141.15%	232.59%	290.98%
Research & Development		$0.00	$0.00
YoY Change
% of Gross Profit		0.0%	0.0%
Depreciation & Amortization	$24.51K	$24.51K	$20.85K
YoY Change	19.3%	17.55%	-8.99%
% of Gross Profit	5.59%	5.16%	7.73%
Operating Expenses	$630.9K	$1.116M	$793.5K
YoY Change	-18.78%	40.7%	-58.99%
Operating Profit	-$192.4K	-$641.5K	-$523.6K
YoY Change	-105.53%	22.52%	-68.72%
Interest Expense			$195.8K
YoY Change			-178.76%
% of Operating Profit
Other Income/Expense, Net	$50.00K	$333.9K	-$199.5K
YoY Change	-83.02%	-267.37%
Pretax Income	-$246.0K	-$307.7K	-$723.1K
YoY Change	-106.52%	-57.45%	-62.33%
Income Tax
% Of Pretax Income
Net Earnings	-$246.0K	-$317.2K	-$723.1K
YoY Change	-106.52%	-56.14%	-62.33%
Net Earnings / Revenue	-28.48%	-33.86%	-140.35%
Basic Earnings Per Share	$0.00	$0.00	$0.00
Diluted Earnings Per Share	$0.00	$0.00	$0.00
COMMON SHARES
Basic Shares Outstanding	545.3M shares	539.1M shares	447.7M shares
Diluted Shares Outstanding	543.2M shares	535.7M shares	425.0M shares

Balance Sheet

Concept	2024 Q2	2024 Q1	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$196.3K	$197.9K	$82.98K
YoY Change	-87.01%	138.44%	-51.22%
Cash & Equivalents	$196.3K	$197.9K	$82.98K
Short-Term Investments
Other Short-Term Assets	$107.8K	$269.7K	$88.85K
YoY Change	61.03%	203.52%	124.26%
Inventory	$162.1K	$101.8K	$59.35K
Prepaid Expenses
Receivables	$243.4K	$507.4K	$198.7K
Other Receivables	$71.96K	$0.00	$0.00
Total Short-Term Assets	$841.4K	$1.085M	$429.9K
YoY Change	-54.05%	152.45%	-26.76%
LONG-TERM ASSETS
Property, Plant & Equipment	$147.8K	$159.7K	$88.08K
YoY Change	87.03%	81.34%	-77.39%
Goodwill	$350.5K	$350.5K	$350.5K
YoY Change	0.0%	0.0%
Intangibles	$204.2K	$216.8K	$267.3K
YoY Change	-19.83%	-18.89%
Long-Term Investments			$7.780K
YoY Change			20.06%
Other Assets
YoY Change
Total Long-Term Assets	$831.2K	$870.8K	$1.060M
YoY Change	-4.55%	-17.87%	-0.37%
TOTAL ASSETS
Total Short-Term Assets	$841.4K	$1.085M	$429.9K
Total Long-Term Assets	$831.2K	$870.8K	$1.060M
Total Assets	$1.673M	$1.956M	$1.490M
YoY Change	-38.09%	31.26%	-9.75%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$798.8K	$702.8K	$828.5K
YoY Change	9.47%	-15.17%	-2.91%
Accrued Expenses	$390.3K	$522.5K	$859.5K
YoY Change	-0.13%	-39.21%	-8.31%
Deferred Revenue	$148.8K	$341.8K
YoY Change
Short-Term Debt	$180.0K	$180.0K	$1.195M
YoY Change	-82.55%	-84.93%	215.98%
Long-Term Debt Due	$474.0K	$232.1K	$1.592M
YoY Change	469.66%	-85.42%	148.78%
Total Short-Term Liabilities	$2.107M	$2.066M	$5.020M
YoY Change	-27.52%	-58.85%	75.85%
LONG-TERM LIABILITIES
Long-Term Debt	$861.6K	$925.5K	$625.7K
YoY Change	15423.78%	47.92%	17.99%
Other Long-Term Liabilities	$67.95K	$82.42K	$227.7K
YoY Change	-47.21%	-63.8%	8.16%
Total Long-Term Liabilities	$929.5K	$1.008M	$853.4K
YoY Change	592.28%	18.11%	15.19%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.107M	$2.066M	$5.020M
Total Long-Term Liabilities	$929.5K	$1.008M	$853.4K
Total Liabilities	$3.037M	$3.074M	$5.874M
YoY Change	-0.15%	-47.66%	55.72%
SHAREHOLDERS EQUITY
Retained Earnings	-$61.45M	-$61.18M	-$63.41M
YoY Change	3.04%	-3.52%
Common Stock	$545.3K	$539.1K	$447.7K
YoY Change	4.21%	20.42%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$4.341M	-$4.303M	-$4.518M
YoY Change
Total Liabilities & Shareholders Equity	$1.673M	$1.956M	$1.490M
YoY Change	-38.09%	31.26%	-9.75%

Cashflow Statement

Concept	2024 Q2	2024 Q1	2023 Q1
OPERATING ACTIVITIES
Net Income	-$246.0K	-$317.2K	-$723.1K
YoY Change	-106.52%	-56.14%	-62.33%
Depreciation, Depletion And Amortization	$24.51K	$24.51K	$20.85K
YoY Change	19.3%	17.55%	-8.99%
Cash From Operating Activities	-$160.8K	-$651.2K	-$291.0K
YoY Change	-74.15%	123.81%	-42.24%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	159.3K	$112.6K	$276.9K
YoY Change	-108.0%	-59.32%	79.81%
NET CHANGE
Cash From Operating Activities	-160.8K	-$651.2K	-$291.0K
Cash From Investing Activities
Cash From Financing Activities	159.3K	$112.6K	$276.9K
Net Change In Cash	-1.540K	-$538.6K	-$14.11K
YoY Change	-100.11%	3717.95%	-95.97%
FREE CASH FLOW
Cash From Operating Activities	-$160.8K	-$651.2K	-$291.0K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	424991656	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	535697745	shares
CY2024Q1	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2023Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	545253623	shares
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	197863	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	736461	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	507416	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	424091	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	101751	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	181663	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	269683	usd
CY2024Q1	dei	Document Type DocumentType	10-Q
CY2024Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q1	dei	Entity Registrant Name EntityRegistrantName	C-BOND SYSTEMS, INC.
CY2024Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	CO
CY2024Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	26-1315585
CY2024Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	2029 Pat Booker Rd
CY2024Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	San Antonio
CY2024Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
CY2024Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	78148
CY2024Q1	dei	City Area Code CityAreaCode	210
CY2024Q1	dei	Local Phone Number LocalPhoneNumber	490-3977
CY2024Q1	dei	Security12b Title Security12bTitle	N/A
CY2024Q1	dei	No Trading Symbol Flag NoTradingSymbolFlag	true
CY2024Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	28503	usd
CY2024Q1	us-gaap	Capitalized Contract Cost Net Current CapitalizedContractCostNetCurrent	8489	usd
CY2023Q4	us-gaap	Capitalized Contract Cost Net Current CapitalizedContractCostNetCurrent	2400	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	1085202	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	1373118	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	159724	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	171606	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	143810	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	158484	usd
CY2024Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	216789	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	229414	usd
CY2024Q1	us-gaap	Goodwill Goodwill	350491	usd
CY2023Q4	us-gaap	Goodwill Goodwill	350491	usd
CY2024Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	870814	usd
CY2023Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	909995	usd
CY2024Q1	us-gaap	Assets Assets	1956016	usd
CY2023Q4	us-gaap	Assets Assets	2283113	usd
CY2024Q1	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	180000	usd
CY2023Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	180000	usd
CY2024Q1	us-gaap	Notes Payable To Bank Current NotesPayableToBankCurrent	232104	usd
CY2023Q4	us-gaap	Notes Payable To Bank Current NotesPayableToBankCurrent	81908	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	702805	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	710222	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	522530	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	474515	usd
CY2024Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	25546	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	717204	usd
CY2024Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	341771	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	500720	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	61390	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	60503	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	2066146	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2725072	usd
CY2024Q1	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	873091	usd
CY2023Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	918091	usd
CY2024Q1	us-gaap	Notes Payable To Bank Noncurrent NotesPayableToBankNoncurrent	52447	usd
CY2023Q4	us-gaap	Notes Payable To Bank Noncurrent NotesPayableToBankNoncurrent	42109	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	82420	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	97249	usd
CY2024Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	1007958	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	1057449	usd
CY2024Q1	us-gaap	Liabilities Liabilities	3074104	usd
CY2023Q4	us-gaap	Liabilities Liabilities	3782521	usd
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.1
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.1
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2024Q1	cbnt	Preferred Stock Shares Designated PreferredStockSharesDesignated	100000	shares
CY2023Q4	cbnt	Preferred Stock Shares Designated PreferredStockSharesDesignated	100000	shares
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	4998000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	4998000000	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	539122586	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	539122586	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	532818051	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	532818051	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	539123	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	532818	usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	56340780	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	55852477	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-61183221	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-60851714	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-4303318	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-4466419	usd
CY2024Q1	us-gaap	Minority Interest MinorityInterest	151394	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	141884	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-4151924	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-4324535	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1956016	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2283113	usd
CY2024Q1	us-gaap	Revenues Revenues	936804	usd
CY2023Q1	us-gaap	Revenues Revenues	515220	usd
CY2024Q1	us-gaap	Cost Of Revenue CostOfRevenue	461929	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	245360	usd
CY2024Q1	us-gaap	Gross Profit GrossProfit	474875	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	269860	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	376968	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	12137	usd
CY2024Q1	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	779119	usd
CY2023Q1	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	426872	usd
CY2024Q1	us-gaap	Professional Fees ProfessionalFees	141584	usd
CY2023Q1	us-gaap	Professional Fees ProfessionalFees	187690	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	195691	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	178900	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	1116394	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	793462	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-641519	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-523602	usd
CY2024Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	347990	usd
CY2024Q1	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	14119	usd
CY2023Q1	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	195786	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	3699	usd
CY2024Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	333871	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-199485	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-307648	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-723087	usd
CY2024Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	9510	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-16722	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-317158	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-706365	usd
CY2024Q1	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	14349	usd
CY2023Q1	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	13687	usd
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-331507	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-720052	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	535697745	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	424991656	shares
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-4324535	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	40000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	127640	usd
CY2024Q1	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	14349	usd
CY2024Q1	cbnt	Adjustment To Additional Paid In Capital Beneficialconversionchargeforissuanceof Series Bpreferredsharesforaccruedcompensation AdjustmentToAdditionalPaidInCapitalBeneficialconversionchargeforissuanceofSeriesBpreferredsharesforaccruedcompensation	326968	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-307648	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-4151924	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-7050669	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	300000	usd
CY2023Q1	cbnt	Stock Issued During Period Value For Professional Fees StockIssuedDuringPeriodValueForProfessionalFees	40000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	53000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	101400	usd
CY2023Q1	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	13687	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	12137	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-723087	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-7280906	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-307648	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-723087	usd
CY2024Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	24507	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	20850	usd
CY2024Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	3789	usd
CY2023Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	63916	usd
CY2023Q1	us-gaap	Paid In Kind Interest PaidInKindInterest	29212	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	376968	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	12137	usd
CY2023Q1	cbnt	Stockbased Professional Fee StockbasedProfessionalFee	40667	usd
CY2024Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	347990	usd
CY2024Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	732	usd
CY2023Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	495	usd
CY2024Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	29984	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	113309	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-70754	usd
CY2024Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-79912	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-18100	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	241180	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	19639	usd
CY2024Q1	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	6089	usd
CY2023Q1	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	-279	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-7417	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	48693	usd
CY2024Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	48015	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	123124	usd
CY2023Q1	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	2466	usd
CY2024Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-32561	usd
CY2023Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	34317	usd
CY2024Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-158949	usd
CY2023Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-13255	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-651236	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-290971	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	275000	usd
CY2024Q1	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	174000	usd
CY2024Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	16362	usd
CY2023Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	48136	usd
CY2023Q1	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	50000	usd
CY2024Q1	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	45000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	112638	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	276864	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-538598	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-14107	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	736461	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	97091	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	197863	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	82984	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	8246	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	33795	usd
CY2023Q1	cbnt	Common Stock Issued As Prepaid For Services CommonStockIssuedAsPrepaidForServices	40000	usd
CY2023Q1	us-gaap	Noncash Or Part Noncash Acquisition Employee Benefit Liabilities Assumed1 NoncashOrPartNoncashAcquisitionEmployeeBenefitLiabilitiesAssumed1	78000	usd
CY2024Q1	cbnt	Preferred Stock Issued For Accrued Compensation PreferredStockIssuedForAccruedCompensation	312000	usd
CY2023Q1	cbnt	Preferred Stock Issued For Accrued Compensation PreferredStockIssuedForAccruedCompensation	144000	usd
CY2024Q1	cbnt	Preferred Stock Dividend Accrued PreferredStockDividendAccrued	14349	usd
CY2023Q1	cbnt	Preferred Stock Dividend Accrued PreferredStockDividendAccrued	13687	usd
CY2024Q1	cbnt	Conversion Of Series C Preferred Stock To Common Stock ConversionOfSeriesCPreferredStockToCommonStock	40000	usd
CY2023Q1	cbnt	Conversion Of Series C Preferred Stock To Common Stock ConversionOfSeriesCPreferredStockToCommonStock	101400	usd
CY2024Q1	cbnt	Reclassification Of Series B Preferred Stock To Additional Paidin Capital ReclassificationOfSeriesBPreferredStockToAdditionalPaidinCapital	132890	usd
CY2024Q1	us-gaap	Nature Of Operations NatureOfOperations	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NOTE 1 – <span style="text-decoration:underline">NATURE OF ORGANIZATION</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Nature of Organization</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">C-Bond Systems, Inc., together with its subsidiaries (the “Company”), is a materials development company and sole owner and developer of the patented C-Bond technology. The Company is engaged in the implementation of proprietary nanotechnology applications and processes to enhance properties of strength, functionality, and sustainability of brittle material systems. The Company’s primary focus is in the multi-billion-dollar glass and window film industry with target markets in the United States and internationally. During the three months ended March 31, 2023, the Company operated in two segments: C-Bond Transportation Solutions and Patriot Glass Solutions. C-Bond Transportation Solutions sold a windshield strengthening, water repellent solution called C-Bond nanoShield™. Since May 8, 2023, the date that the nanoShield product line and related technologies were sold (see Note 16), the Company operates in one segment. Patriot Glass Solutions sells multi-purpose glass strengthening primer and window film mounting solutions, including C-Bond BRS, a ballistic-resistant film system, and C-Bond Secure, a forced entry system.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 30, 2021, the Company entered into a Share Exchange Agreement and Plan of Reorganization (the “Exchange Agreement”) with (i) Patriot Glass Solutions, LLC (formerly Mobile Tint LLC), a Texas limited liability company doing business as A1 Glass Coating (“Patriot Glass”), (ii) the sole member of Patriot Glass (the “Patriot Glass Shareholder”), and (iii) Michael Wanke as the Representative of the Patriot Glass Shareholder. Pursuant to the Exchange Agreement, on July 22, 2021, the Company acquired 80% of Patriot Glass’s units (the “Patriot Glass Shares”). The Patriot Glass Shares were exchanged for 28,021,016 restricted shares of the Company’s common stock in an amount equal to $800,000, divided by the average of the closing prices of the Company’s common stock during the 30-day period immediately prior to the closing. On September 20, 2023, the Company and the Patriot Glass Shareholder entered into amendment #2 to the Exchange Agreement (the “Amended Exchange Agreement”). Pursuant to the Amended Exchange Agreement, the Company shall have the option (the “Option”), beginning on July 1, 2025 (the “Option Start Date”) and ending on 5:00 P.M. EST on the date that is thirty calendar days after the Option Start Date (the “Option Period”), to acquire the remaining 20% of Patriot Glass Units (the “Additional Units”), representing 20% of Patriot Glass’s issued and outstanding membership interests, collectively (the “Additional Closing”) (See Note 10). Patriot Glass provides quality window tint solutions for auto, home, and business owners across Texas, specializing in automotive window tinting, residential window film, and commercial window film that stop harmful UV rays from passing through its window films for reduced glare, comfortable temperatures, and lower energy bills. Patriot Glass also carries products that offer forced-entry protection and films that protect glass from scratches, graffiti, other types of vandalism, and even bullets, including C-Bond BRS and C-Bond Secure products. As part of the transaction, Patriot Glass’s owner-operator, Mr. Wanke, joined the Company as President of Patriot Glass. On November 29, 2023, the name of Mobile Tint LLC was changed to Patriot Glass Solutions, LLC.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On May 8, 2023, the Company entered into an Asset Purchase Agreement (“APA”) with Apex Protect GPS, LLC (the “Buyer”), whereby the Company sold its C-Bond nanoShield™ product line, including intangible assets, intellectual property, work in process, furniture, fixtures, equipment, inventory and other physical assets of the Company’s C-Bond nanoShield division (the “Assets”) to the Buyer. Accordingly, the Company assigned, transferred and delivered to the Buyer, free and clear of all liens, all of the Assets. Following the Closing, the Parties entered into an Assignment and Agreement to Re-Execute (“Assignment”) on June 15, 2023, by and among the Company (“Seller”); Apex Protect GPS, LLC, (“Assignor”) and CB Nanoshield, LLC, (“Assignee”), whereby the Assignor assigned all its right to the (i) APA; (ii) Bill of Sale (iii) IP Agreements; and (iv) and any memorandums, schedules and exhibits related to the foregoing to Assignee. The Seller and Assignee also entered into a Lease and Assignment and Assumption Agreement on June 15, 2023 (the “Assignment Agreement”), wherein the Seller assigned to Assignee, and Assignee took assignment from the Seller, of the lease for the premises located at 6035 South Loop East, Houston, Texas 77033 (the “Lease”) pursuant to the Assignment Agreement (See Note 16).</p>
CY2023Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	pure
CY2023Q2	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	pure
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-307648	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-723087	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-651236	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-290971	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-61183221	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-4151924	usd
CY2024Q1	cbnt	Working Capital WorkingCapital	980944	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	197863	usd
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Use of Estimates</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of consolidated financial statements in conformity with U.S. generally accepted accounting principles (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. Estimates during the three months ended March 31, 2024 and 2023 include estimates for allowance for doubtful accounts on accounts receivable, the estimates for obsolete or slow moving inventory, estimates used in the calculation of progress towards completion on uncompleted jobs, the useful life of property and equipment, assumptions used in assessing impairment of long-term assets, the estimate of the fair value lease liability and related right of use asset, the valuation of redeemable and mandatorily redeemable preferred stock, the value of beneficial conversion features and deemed dividends, the valuation allowances for deferred tax assets, and the fair value of non-cash equity transactions. </p>
CY2023	us-gaap	Number Of Reporting Units NumberOfReportingUnits	1	pure
CY2024Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1000	usd
CY2024Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	0	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	0	usd
CY2024Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2059971417	shares
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1997216731	shares
CY2023Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segments
CY2024Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Risk and Uncertainties</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company operates in an industry that is subject to intense competition and changes in consumer and commercial demand. The Company’s operations are subject to significant risk and uncertainties including financial and operational risks including the potential risk of business failure.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has experienced, and in the future expects to continue to experience, variability in sales and earnings. The factors expected to contribute to this variability include, among others, (i) the cyclical nature of the business, (ii) general economic conditions in the various local markets in which the Company competes, including a potential general downturn in the economy, and (iii) the volatility of prices in connection with the Company’s products and services. These factors, among others, make it difficult to project the Company’s operating results on a consistent basis.</p>
CY2024Q1	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	572723	usd
CY2023Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	459414	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	65307	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	35323	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	507416	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	424091	usd
CY2024Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	29984	usd
CY2024Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	101751	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	181663	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	101751	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	181663	usd
CY2024Q1	cbnt	Future Financings Percentage FutureFinancingsPercentage	0.30	pure
CY2022Q2	us-gaap	Debt Instrument Convertible Conversion Price Decrease DebtInstrumentConvertibleConversionPriceDecrease	0.00875
CY2024Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	254167	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	254167	usd
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	94443	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	82561	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	159724	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	171606	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	352516	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	352516	usd
CY2024Q1	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	135727	usd
CY2023Q4	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	123102	usd
CY2024Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	216789	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	229414	usd
CY2024Q1	us-gaap	Goodwill Goodwill	350491	usd
CY2023Q4	us-gaap	Goodwill Goodwill	350491	usd
CY2024Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	12625	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	12626	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	50503	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	50503	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	15783	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	116789	usd
CY2024Q1	cbnt	Outstanding Principal Balance Rate OutstandingPrincipalBalanceRate	1.25	pure
CY2024Q1	cbnt	Accrued Interest Rate Per Anum AccruedInterestRatePerAnum	0.18	pure
CY2024Q1	cbnt	Debt Instrument Trading Days DebtInstrumentTradingDays	P10D
CY2024Q1	us-gaap	Derivative Net Assets Percentage DerivativeNetAssetsPercentage	0.50	pure
CY2022Q4	us-gaap	Debt Default Longterm Debt Amount DebtDefaultLongtermDebtAmount	206250	usd
CY2022Q4	us-gaap	Debt Instrument Redemption Price Percentage Of Principal Amount Redeemed DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed	0.25	pure
CY2022Q4	us-gaap	Long Term Debt Percentage Bearing Variable Interest Rate LongTermDebtPercentageBearingVariableInterestRate	0.18	pure
CY2023Q4	cbnt	Aggregate Payment AggregatePayment	1113091	usd
CY2024Q1	cbnt	Gross Proceeds GrossProceeds	0.20	pure
CY2024Q1	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	120000	usd
CY2023Q4	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	15000	usd
CY2024Q1	cbnt	Principal And Accrued Interest PrincipalAndAccruedInterest	0.20	pure
CY2024Q1	us-gaap	Deposit Liabilities Accrued Interest DepositLiabilitiesAccruedInterest	176184	usd
CY2022Q3	us-gaap	Debt Instrument Convertible Conversion Price Decrease DebtInstrumentConvertibleConversionPriceDecrease	0.009
CY2022Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.009
CY2022Q4	us-gaap	Debt Instrument Unamortized Premium DebtInstrumentUnamortizedPremium	90731	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Premium DebtInstrumentUnamortizedPremium	90731	usd
CY2023Q2	us-gaap	Debt Instrument Unamortized Premium DebtInstrumentUnamortizedPremium	119943	usd
CY2023Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	119943	usd
CY2024Q1	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	1053091	usd
CY2023Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	1098091	usd
CY2024Q1	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	1053091	usd
CY2023Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	1098091	usd
CY2024Q1	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	180000	usd
CY2023Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	180000	usd
CY2024Q1	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	873091	usd
CY2023Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	918091	usd
CY2024Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	314862	usd
CY2023Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	124781	usd
CY2024Q1	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	30311	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	764	usd
CY2024Q1	us-gaap	Notes Payable To Bank NotesPayableToBank	284551	usd
CY2023Q4	us-gaap	Notes Payable To Bank NotesPayableToBank	124017	usd
CY2024Q1	us-gaap	Notes Payable To Bank Current NotesPayableToBankCurrent	232104	usd
CY2023Q4	us-gaap	Notes Payable To Bank Current NotesPayableToBankCurrent	81908	usd
CY2024Q1	us-gaap	Notes Payable To Bank Noncurrent NotesPayableToBankNoncurrent	52447	usd
CY2023Q4	us-gaap	Notes Payable To Bank Noncurrent NotesPayableToBankNoncurrent	42109	usd
CY2023Q2	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	132000	usd
CY2023Q2	us-gaap	Interest Expense Long Term Debt InterestExpenseLongTermDebt	317293	usd
CY2023Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	18900	usd
CY2022Q2	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	176000	usd
CY2022Q2	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	148420	usd
CY2023Q2	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	62000	usd
CY2023Q2	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	62000	usd
CY2023Q2	us-gaap	Legal Fees LegalFees	2250	usd
CY2023Q2	us-gaap	Legal Fees LegalFees	2250	usd
CY2022Q3	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	176000	usd
CY2022Q3	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	158920	usd
CY2022	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	998008	shares
CY2023Q2	us-gaap	Deposit Liabilities Accrued Interest DepositLiabilitiesAccruedInterest	160880	usd
CY2022Q3	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	176000	usd
CY2022Q3	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	158920	usd
CY2022Q3	cbnt	Maturity Terms MaturityTerms	P12M
CY2022Q3	cbnt	Common Stock Trading Price Per Share CommonStockTradingPricePerShare	0.009
CY2024Q1	us-gaap	Investment Interest Rate InvestmentInterestRate	0.12	pure
CY2024Q1	us-gaap	Shortterm Debt Average Outstanding Amount ShorttermDebtAverageOutstandingAmount	157000	usd
CY2023	us-gaap	Shortterm Debt Average Outstanding Amount ShorttermDebtAverageOutstandingAmount	0	usd
CY2022Q4	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	200000	usd
CY2022Q4	cbnt	Outstanding Interest Rate Percentage OutstandingInterestRatePercentage	0.08	pure
CY2024Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	3789	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	62323	usd
CY2024Q1	cbnt	Preferred Stock Convertible Conversion Percentage PreferredStockConvertibleConversionPercentage	1	pure
CY2024Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	281807	usd
CY2024Q1	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	281807	usd
CY2024Q1	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	312000	usd
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	0.059
CY2024Q1	us-gaap	Employee Benefits And Share Based Compensation Noncash EmployeeBenefitsAndShareBasedCompensationNoncash	95161	usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	0.059
CY2024Q1	us-gaap	Dividends Dividends	58598	usd
CY2024Q1	us-gaap	Preferred Stock Redemption Amount PreferredStockRedemptionAmount	20000	usd
CY2024Q1	us-gaap	Dividends Payable Current DividendsPayableCurrent	7455	usd
CY2023Q1	us-gaap	Dividends Payable Current DividendsPayableCurrent	8169	usd
CY2024Q1	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	1588615	usd
CY2024Q1	cbnt	Preferred Stock Stated Value PreferredStockStatedValue	1475000	usd
CY2024Q1	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	113615	usd
CY2023	cbnt	Preferred State Value Inclued Liquidations PreferredStateValueIncluedLiquidations	1515000	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	300000
CY2023Q1	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	275000	shares
CY2023Q1	cbnt	Stock Issued During Period Value For Accrued Compensation StockIssuedDuringPeriodValueForAccruedCompensation	53000	usd
CY2023Q1	cbnt	Stock Issued During Period Shares For Accrued Compensation StockIssuedDuringPeriodSharesForAccruedCompensation	9636364	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6666667	shares
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	12137	usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	40000	usd
CY2023Q1	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.006
CY2023Q1	cbnt	Stockbased Professional Fees stockbasedProfessionalFees	11667	usd
CY2023Q1	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	28333	usd
CY2024Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	0	usd
CY2024Q1	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Expense UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense	0	usd
CY2023	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Expense UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense	0	usd
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	14970120	shares
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	0.132
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	14970120	shares
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	0.132
CY2024Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	0	usd
CY2023Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	0	usd
CY2024Q1	cbnt	Voting Percentage VotingPercentage	0.10	pure
CY2024Q1	cbnt	Fair Market Percentage FairMarketPercentage	1.10	pure
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	50000000	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	11445698	shares
CY2024Q1	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	29451070	shares
CY2024Q1	us-gaap	Cash Cash	21961	usd
CY2024Q1	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	175000	usd
CY2023	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	175000	usd
CY2024Q1	us-gaap	Escrow Deposit EscrowDeposit	225000	usd
CY2024Q1	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	120	shares
CY2024Q1	us-gaap	Stock Issued During Period Shares Share Based Compensation Forfeited StockIssuedDuringPeriodSharesShareBasedCompensationForfeited	5250000	shares
CY2023	us-gaap	Extinguishment Of Debt Amount ExtinguishmentOfDebtAmount	347097	usd
CY2017Q4	cbnt	Annual Base Salary AnnualBaseSalary	300000	usd
CY2017Q4	cbnt	Annual Base Salary Rate AnnualBaseSalaryRate	0.10	pure
CY2017Q4	us-gaap	Public Utilities Amount Of Allowance For Funds Used During Construction Equity Costs Capitalized Only For Rate Making Purposes PublicUtilitiesAmountOfAllowanceForFundsUsedDuringConstructionEquityCostsCapitalizedOnlyForRateMakingPurposes	1000000	usd
CY2017Q4	cbnt	Capital Raise Rate CapitalRaiseRate	0.05	pure
CY2017Q4	cbnt	Common Stock Shares Acquired CommonStockSharesAcquired	3000000	shares
CY2017Q4	cbnt	Common Stock Shares Acquired Per Share CommonStockSharesAcquiredPerShare	0.31
CY2017Q4	cbnt	Stock Options Shares Issued StockOptionsSharesIssued	500000	shares
CY2017Q4	cbnt	Strike Price StrikePrice	0.85
CY2021Q3	us-gaap	Salaries And Wages SalariesAndWages	240000	usd
CY2021Q3	cbnt	Base Salaries Percentage BaseSalariesPercentage	0.50	pure
CY2024Q1	cbnt	Base Salary Bonus Percentage BaseSalaryBonusPercentage	0.50	pure
CY2023	cbnt	Bonus Percentage BonusPercentage	0.10	pure
CY2023	us-gaap	Equity Method Investment Sold Carrying Amount EquityMethodInvestmentSoldCarryingAmount	162000	usd
CY2024Q1	us-gaap	Accrued Bonuses Current And Noncurrent AccruedBonusesCurrentAndNoncurrent	312000	usd
CY2024Q1	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	312	shares
CY2016Q4	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.85
CY2024Q1	cbnt	Issued Percentage IssuedPercentage	0.20	pure
CY2024Q1	cbnt	Outstanding Percentage OutstandingPercentage	0.20	pure
CY2024Q1	cbnt	Common Stock Percentage CommonStockPercentage	3	pure
CY2024Q1	cbnt	Option Period Percentage OptionPeriodPercentage	0.20	pure
CY2023Q3	us-gaap	Interest Expense Other InterestExpenseOther	240000	usd
CY2023Q3	cbnt	Share Value Percentage ShareValuePercentage	3	pure
CY2024Q1	cbnt	Nonrefundable Cash Fee NonrefundableCashFee	25000	usd
CY2024Q1	cbnt	Transaction Percentage TransactionPercentage	0.065	pure
CY2024Q1	cbnt	Break Up Fee Percentage BreakUpFeePercentage	0.10	pure
CY2024Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	pure
CY2024Q1	us-gaap	Revenues Revenues	936804	usd
CY2023Q1	us-gaap	Revenues Revenues	515220	usd
CY2024Q1	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	11882	usd
CY2023Q1	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	20850	usd
CY2024Q1	us-gaap	Interest And Debt Expense InterestAndDebtExpense	14119	usd
CY2023Q1	us-gaap	Interest And Debt Expense InterestAndDebtExpense	199485	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-307648	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-723087	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	159724	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	171606	usd
CY2024Q1	us-gaap	Revenues Revenues	936804	usd
CY2023Q1	us-gaap	Revenues Revenues	515220	usd
CY2020	us-gaap	Payments For Rent PaymentsForRent	4444	usd
	us-gaap	Payments For Rent PaymentsForRent	4577	usd
CY2022Q2	us-gaap	Lessee Operating Lease Remaining Lease Term LesseeOperatingLeaseRemainingLeaseTerm	P1Y
CY2022Q2	us-gaap	Payments For Rent PaymentsForRent	5283	usd
CY2024Q1	us-gaap	Payments For Rent PaymentsForRent	5600	usd
CY2021Q3	us-gaap	Payments For Rent PaymentsForRent	365	usd
CY2022Q1	us-gaap	Payments For Rent PaymentsForRent	788	usd
CY2024Q1	us-gaap	Sale Leaseback Transaction Lease Term SaleLeasebackTransactionLeaseTerm	P12M
CY2024Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	16800	usd
CY2023Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	40845	usd
CY2024Q1	cbnt	Office Leases Right Of Use Assets OfficeLeasesRightOfUseAssets	279162	usd
CY2023Q4	cbnt	Office Leases Right Of Use Assets OfficeLeasesRightOfUseAssets	279162	usd
CY2024Q1	cbnt	Operating Lease Right Of Use Asset Amortization Accumulated Amortization OperatingLeaseRightOfUseAssetAmortizationAccumulatedAmortization	135352	usd
CY2023Q4	cbnt	Operating Lease Right Of Use Asset Amortization Accumulated Amortization OperatingLeaseRightOfUseAssetAmortizationAccumulatedAmortization	120678	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	143810	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	158484	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	143810	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	157752	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	61390	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	60503	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	82420	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	97249	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	75078	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	67200	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	22400	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	164678	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	20868	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	143810	usd
CY2022Q2	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	250000	usd
CY2022Q2	us-gaap	Long Term Debt Percentage Bearing Fixed Interest Rate LongTermDebtPercentageBearingFixedInterestRate	0.06	pure
CY2022Q2	us-gaap	Debt Conversion Original Debt Due Date Of Debt Day Month And Year DebtConversionOriginalDebtDueDateOfDebtDayMonthAndYear	2024-05-02
CY2023Q1	us-gaap	Interest Expense InterestExpense	3699	usd
CY2023Q2	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	200000	usd
CY2023Q3	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	50000	usd
CY2023Q3	us-gaap	Interest Expense InterestExpense	15690	usd
CY2023Q1	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	4000000	usd
CY2024Q1	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt	1989755	usd
CY2023Q2	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	4051709	usd
CY2024Q2	us-gaap	Customer Funds CustomerFunds	100000	usd
CY2024Q2	cbnt	Interest Charge Rate Percentage InterestChargeRatePercentage	0.12	pure
CY2024Q1	cbnt	Guarantor Obligations Liquidation Proceeds Percentage GuarantorObligationsLiquidationProceedsPercentage	2.20	pure
CY2024Q1	cbnt	Conversion Price Percentage ConversionPricePercentage	0.65	pure
CY2024Q1	cbnt	Discount Rates DiscountRates	0.35	pure
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q1	us-gaap	Interest Expense InterestExpense		usd
CY2024Q1	us-gaap	Paid In Kind Interest PaidInKindInterest		usd
CY2024Q1	cbnt	Stockbased Professional Fee StockbasedProfessionalFee		usd
CY2023Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts		usd
CY2024Q1	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties		usd
CY2024Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2023Q1	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable		usd
CY2024Q1	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		usd
CY2023Q1	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt		usd
CY2024Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2023Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2024Q1	cbnt	Common Stock Issued As Prepaid For Services CommonStockIssuedAsPrepaidForServices		usd
CY2024Q1	us-gaap	Noncash Or Part Noncash Acquisition Employee Benefit Liabilities Assumed1 NoncashOrPartNoncashAcquisitionEmployeeBenefitLiabilitiesAssumed1		usd
CY2023Q1	cbnt	Reclassification Of Series B Preferred Stock To Additional Paidin Capital ReclassificationOfSeriesBPreferredStockToAdditionalPaidinCapital		usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts		usd
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares		shares
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
CY2024Q1	dei	Amendment Flag AmendmentFlag	false
CY2024Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2024Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001421636

Files In Submission

Name	View Source	Status
0001213900-24-042971-index-headers.html	Edgar Link	pending
0001213900-24-042971-index.html	Edgar Link	pending
0001213900-24-042971.txt	Edgar Link	pending
0001213900-24-042971-xbrl.zip	Edgar Link	pending
cbnt-20240331.xsd	Edgar Link	pending
ea0205862-10q_cbond.htm	Edgar Link	pending
ea020586201ex31-1_cbond.htm	Edgar Link	pending
ea020586201ex31-2_cbond.htm	Edgar Link	pending
ea020586201ex32-1_cbond.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
cbnt-20240331_cal.xml	Edgar Link	unprocessable
cbnt-20240331_def.xml	Edgar Link	unprocessable
cbnt-20240331_lab.xml	Edgar Link	unprocessable
cbnt-20240331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
ea0205862-10q_cbond_htm.xml	Edgar Link	completed
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CBNT
C-Bond Systems, Inc Stock $cbnt

2024 Q2 Form 10-Q Financial Statement

#000121390024042971 Filed on May 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CBNT C-Bond Systems, Inc Stock $cbnt

2024 Q2 Form 10-Q Financial Statement

#000121390024042971 Filed on May 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CBNT
C-Bond Systems, Inc Stock $cbnt